Tag Archives: JBS3

FH: improving detection in primary care The launch of the NICE (National Institute of Health and Care Excellence) guidelines for familial hypercholesterolaemia (FH) heralded great optimism for improving detection rates in primary care.1 Even with new research showing that FH is more common than previously thought,2  still around 80% of patients are not recognised. Novel detection approaches are clearly needed. Professor Nadeem Qureshi (University of Nottingham) presented preliminary findings from six GP centres taking part in FAMCHOL (Feasibility of Improving Identification of Familial Hypercholesterolaemia in General Practice: Intervention

Terry McCormack (BJC Editor, and General Practitioner) Another theme is coronary artery disease diagnosis with one article suggesting that following NICE guideline CG95 will reduce unnecessary computed tomography angiography (see page 78) whilst two other articles question whether the same guidance leads to too many invasive coronary angiograms (pages 75 and 77). We also cover exercise for heart failure (page 76), atrial fibrillation screening (pages 64−8), radiation exposure (pages 72−4) and Raza Alikhan explains how to combat haemorrhage from ODIs (pages 69−71). ODIs stands for oral direct inhibitors, which most people now know as ne

This emphasis on short-term risk means the long-term consequences of modifiable risk factors may be overlooked. Age and male gender are currently the biggest drivers of risk, said Professor John Deanfield (Chair of JBS3 and British Heart Foundation Chair of Cardiology at UCL, London) at a launch event for the JBS3 recommendations. Treatment has favoured elderly men, with risk calculators disenfranchising the young, especially women, he added. The report, which the British Cardiovascular Society calls “an evolution in CVD prevention,” supports intensive management of people at high lifetime risk for CVD. Its message that early inte